Bohnen Shane 4

Accession 0001062993-24-015382

CIK 0000842023other

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 5:28 PM ET

Size

26.6 KB

Accession

0001062993-24-015382

Form 4

Period: 2024-08-15

SVP - General Counsel

Transactions

Exercise/Conversion
Common Stock
2024-08-15+49→ 1,696 total
Award
Performance Restricted Stock Units
2024-08-15+10,012→ 10,012 total
→ Common Stock (10,012 underlying)
Tax Payment
Common Stock
2024-08-15$74.91/sh−15$1,124→ 1,681 total
Exercise/Conversion
Restricted Stock Units
2024-08-15−49→ 99 total
→ Common Stock (49 underlying)
Award
Restricted Stock Units
2024-08-15+5,006→ 5,006 total
→ Common Stock (5,006 underlying)
Award
Stock Option (Right to Buy)
2024-08-15+13,488→ 13,488 total
Exercise: $74.91Exp: 2034-08-15→ Common Stock (13,488 underlying)

Holdings

Stock Option (Right to Buy)
Exercise: $120.46Exp: 2028-08-06→ Common Stock (3,460 underlying)
3,460
Stock Option (Right to Buy)
Exercise: $94.52Exp: 2029-08-15→ Common Stock (3,508 underlying)
3,508
Stock Option (Right to Buy)
Exercise: $73.76Exp: 2030-04-03→ Common Stock (3,928 underlying)
3,928
Restricted Stock Units
→ Common Stock (4,519 underlying)
4,519
Performance Restricted Stock Units
→ Common Stock (4,802 underlying)
4,802
Stock Option (Right to Buy)
Exercise: $84.61Exp: 2030-08-15→ Common Stock (16,302 underlying)
16,302
Performance Stock Option (Right to Buy)
Exercise: $84.61→ Common Stock (12,924 underlying)
12,924
Stock Option (Right to Buy)
Exercise: $66.97Exp: 2027-08-05→ Common Stock (8,944 underlying)
8,944
Stock Option (Right to Buy)
Exercise: $47.60Exp: 2026-08-07→ Common Stock (8,848 underlying)
8,848

Footnotes (12)

[F1]Fully exercisable.
[F10]Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
[F11]1,668 restricted stock units vest on 8/15/2025, and 1,669 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
[F12]Options to purchase 3,372 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
[F2]Options to purchase 864 shares vest on each of 8/6/2022, 8/6/2024 and 8/6/2025, and options to purchase 868 shares vest on 8/6/2023.
[F3]Options to purchase 876 shares vest on each of 8/15/2023, 8/15/2025 and 8/15/2026, and options to purchase 880 shares vest on 8/15/2024.
[F4]Options to purchase 982 shares vest on each of 4/3/2024, 4/3/2025, 4/3/2026 and 4/3/2027.
[F5]Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
[F6]2,260 restricted stock units vest on 4/3/2025 and 2,259 restricted stock units vest on 4/3/2026.
[F7]Options to purchase 4,076 shares vest on 8/15/2024 and 8/15/2026, and options to purchase 4,075 shares vest on 8/15/2025 and 8/15/2027.
[F8]49 restricted stock units vest on 8/15/2024 and 8/15/2026, and 50 restricted stock units vest on 8/15/2025
[F9]Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

Documents

1 file

BIO-TECHNE Corp

CIK 0000842023

Entity typeother